Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Raaj Medisafe India Ltd

RAAJMEDI
BSE
86.98
1.70%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Raaj Medisafe India Ltd

RAAJMEDI
BSE
86.98
1.70%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
143Cr
Close
Close Price
86.98
Industry
Industry
Packaging - Plastic Containers
PE
Price To Earnings
13.42
PS
Price To Sales
1.80
Revenue
Revenue
79Cr
Rev Gr TTM
Revenue Growth TTM
66.09%
PAT Gr TTM
PAT Growth TTM
133.24%
Peer Comparison
How does RAAJMEDI stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
RAAJMEDI
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
101111101111111524161821
Growth YoY
Revenue Growth YoY%
25.93.221.56.517.63.7-2.643.5114.845.168.742.0
Expenses
ExpensesCr
891099991221131617
Operating Profit
Operating ProfitCr
112222223334
OPM
OPM%
15.411.614.114.920.415.915.915.212.816.614.917.8
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000011111
Depreciation
DepreciationCr
000000000001
PBT
PBTCr
111121112122
Tax
TaxCr
00001000-1000
PAT
PATCr
111111113122
Growth YoY
PAT Growth YoY%
600.03.3-0.9-13.825.054.0-8.59.6397.150.578.383.5
NPM
NPM%
5.86.09.59.26.28.98.97.114.39.29.49.1
EPS
EPS
0.50.61.00.90.70.70.70.82.61.11.31.4

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
0245522323539436279
Growth
Revenue Growth%
42,531.2146.14.43.9354.445.99.111.312.044.327.1
Expenses
ExpensesCr
1255620283033375467
Operating Profit
Operating ProfitCr
-1000-124567912
OPM
OPM%
-14,440.9-17.0-2.0-9.9-16.46.912.814.714.515.313.815.3
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
011111111224
Depreciation
DepreciationCr
000001111112
PBT
PBTCr
-1-1-1-1-20344457
Tax
TaxCr
0000000101-1-1
PAT
PATCr
-1-1-1-1-20233369
Growth
PAT Growth%
-149.39.123.0-71.7-11.781.9896.031.010.50.084.239.6
NPM
NPM%
-28,118.2-60.0-18.8-30.9-33.2-1.37.28.78.67.79.810.8
EPS
EPS
-2.4-2.1-1.7-2.9-3.2-0.32.12.83.13.14.66.5

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
5555511111111111313
Reserves
ReservesCr
-8-9-10-11-13-12-10-7-301416
Current Liabilities
Current LiabilitiesCr
02333771011162841
Non Current Liabilities
Non Current LiabilitiesCr
7788108967151419
Total Liabilities
Total LiabilitiesCr
4565514172026416989
Current Assets
Current AssetsCr
12222671015183035
Non Current Assets
Non Current AssetsCr
34433791011234054
Total Assets
Total AssetsCr
4565514172026416989

Cash Flow

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
0000-1-122040
Investing Cash Flow
Investing Cash FlowCr
-2-1-1000-3-1-2-13-16
Financing Cash Flow
Financing Cash FlowCr
3010111-11917
Net Cash Flow
Net Cash FlowCr
00000000000
Free Cash Flow
Free Cash FlowCr
-20-10-1-1-11-2-7-13
CFO To PAT
CFO To PAT%
15.3-13.327.40.786.3355.396.981.25.2128.4-1.4
CFO To EBITDA
CFO To EBITDA%
29.7-46.9252.02.1174.4-68.054.848.13.164.5-1.0

Ratios

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5400001543265997
Price To Earnings
Price To Earnings
0.00.00.00.00.00.06.514.27.717.715.8
Price To Sales
Price To Sales
2.30.00.00.00.00.51.20.71.41.6
Price To Book
Price To Book
-1.8-1.00.00.00.00.014.110.33.45.43.6
EV To EBITDA
EV To EBITDA
-19.9-38.1-99.7-20.5-14.77.86.911.07.312.815.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
-192.645.049.246.333.430.531.433.430.432.329.9
OPM
OPM%
-14,440.9-17.0-2.0-9.9-16.46.912.814.714.515.313.8
NPM
NPM%
-28,118.2-60.0-18.8-30.9-33.2-1.37.28.78.67.79.8
ROCE
ROCE%
-19.8-15.1-7.8-24.5-22.911.023.725.921.115.912.0
ROE
ROE%
40.126.817.022.620.124.3214.572.644.530.722.8
ROA
ROA%
-27.0-20.6-14.4-27.5-31.1-2.113.815.412.98.18.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Raaj Medisafe India Ltd. is an Indian manufacturer specializing in high-quality packaging solutions and disposable hygiene products. Historically a single-segment entity focused on plastic packaging, the company has recently undergone a significant strategic transformation, diversifying into the high-growth hygiene sector and expanding its footprint in the alcoholic beverage packaging market. ### Diversified Business Verticals & Product Portfolio The company operates through two primary reportable business segments, catering to the pharmaceutical, FMCG, personal care, and alco-bev sectors. | Segment | Key Product Categories | Material Focus | |:---|:---|:---| | **Plastic Packaging** | HDPE containers, PP Closures, PET Bottles, Caps & Plugs, Plastic Liners, Aluminum Crown Caps, Polybags, and Fabric & Plastic Plugs. | **PET**, **PP**, and **HDPE** resins. | | **Hygiene Products** | Sanitary Napkins, Baby Diapers, Adult Diapers, and Maternity products. | Disposable, high-absorbent materials. | **Strategic Material Substitution:** A core component of the company’s value proposition is the transition of industry standards from traditional metal cans, glass, and aluminum tubes to **Rigid Plastic**. This shift is driven by the superior recyclability, cost-efficiency, and presentation capabilities of advanced plastic resins. ### Manufacturing Infrastructure & Capacity Expansion The company operates across multiple industrial sites in Madhya Pradesh and is expanding into Goa. Following the commencement of commercial production at its newest facility in **July 2024**, the company has significantly scaled its output. * **Unit I (Ujjain):** Located at Industrial Area, Maksi Road; serves as the registered office and primary plastic manufacturing hub. * **Unit II (Pithampur):** Located at Sector III, Industrial Area, Pithampur, Dist. Dhar. * **Unit III (New Expansion - Pithampur):** Located at Plot No. 46, Sector III. This facility houses the plant and machinery for **Sanitary Napkin** production, which commenced operations on **July 9, 2024**. * **Goa Facility (Proposed):** Following the **March 2026** approval to acquire the business of **Fabrizo Industries Private Limited** for **₹28.00 Crores**, the company is establishing a presence in Goa to target the **liquor caps and closure** market. **Capacity Metrics:** * **Current Capacity:** **2,100 MTPA** (currently operating at **100% utilization**). * **Proposed Expansion:** An additional **1,500 MTPA** is planned via a **₹15.00 Crore** capital expenditure program to meet rising demand in flexible packaging and hygiene markets. ### Market Dynamics & Growth Drivers Raaj Medisafe leverages high-growth domestic markets, with a particularly strong foothold in the **Northern (35% share)** and **Western (32% share)** regions of India. * **Rigid Plastics:** Projected to grow at a **CAGR of 10-12%** by **FY25**, fueled by modern retail formats and the demand for low-cost, recyclable packaging. * **Baby Diapers:** The Indian market is valued at **US$ 1.6 Billion (2023)** and is expanding at **23% per annum**. With **2.5 crore** annual births and rising disposable income, volume is expected to reach **140 crore kg by 2029**. * **Alco-Bev Packaging:** The acquisition of Fabrizo Industries marks a strategic entry into the specialized liquor closures market, diversifying the revenue base beyond pharma and FMCG. ### Financial Performance & Capital Structure The company has demonstrated a sharp acceleration in turnover and net worth, particularly following the 2024-25 expansion. | Metric (INR in Thousands) | FY 2024-25 | FY 2023-24 | FY 2022-23 | | :--- | :--- | :--- | :--- | | **Turnover** | **624,204.43** | **432,488.09** | **386,231.00** | | **Revenue Growth (YoY)** | **44.33%** | **11.98%** | **11.32%** | | **Profit Before Tax (PBT)** | **67,033.03** | **51,260.36** | **45,238.00** | | **Earnings Per Share (EPS)** | **₹4.60** | **₹3.07** | **₹3.06** | | **Net Worth** | **269,154.22** | **108,367.17** | **74,908.00** | **Funding & Equity Strategy:** * **Preferential Allotments:** Raised **₹10.01 Crores** in 2024 (at **₹44/share**) and **₹18.01 Crores** in 2026 (at **₹55/share**) to fund diversification. * **Authorized Capital:** Increased in stages from **₹12.25 Crores** to **₹18.00 Crores**. * **Debt Management:** * **HDFC Bank:** **₹2.06 Crore** term loan (61-month tenure). * **Bank of Baroda:** **₹9.77 Crore** sanctioned facility for hygiene expansion; repayments of **₹10 Lakh/month** commence in **April 2025**. * **Borrowing Limits:** Shareholders have authorized the Board to borrow up to **₹300 Crores** to support aggressive growth. ### Governance & Strategic Leadership Effective **August 14, 2024**, the company restructured its leadership to align with its growth phase: * **Shri Arpit Bangur:** Elevated to **Managing Director**. * **Shri Navin Jhawar:** Re-designated as **Whole-time Director**. **Related Party Ecosystem:** The company maintains strategic contracts with group entities to optimize its supply chain and operational scale: * **Shriji Polymers (India) Limited:** Transactions up to **₹14 Crores**. * **Shriniwas Polyfabrics and Packwell Private Limited:** Transactions up to **₹16 Crores**. ### Risk Profile & Mitigation Framework The company identifies **execution quality** and **cost leadership** as its primary competitive moats. * **Operational Risks:** Exposure to **Raw Material (RM) volatility** and competitive pricing pressures. Mitigation involves an internal audit department that monitors key business parameters and logistics efficiency. * **Regulatory & Legal:** The company is contesting a **₹35.70 Lakh** direct tax addition (AY 2018-19) and a minor **₹1.65 Lakh** IGST penalty related to an expired E-way bill. * **Governance Transition:** In September 2024, two long-standing Independent Directors (Shri Rajesh Kumar Gupta and Shri Vijendra Kumar Sood) retired following the completion of their statutory **10-year tenure**. * **Dividend Policy:** The Board has prioritized capital reinvestment over dividends in recent cycles to fund the **₹15 Crore** capacity expansion and the **₹28 Crore** Goa acquisition.